In:
American Journal of Nephrology, S. Karger AG, Vol. 37, No. 5 ( 2013), p. 452-461
Kurzfassung:
〈 b 〉 〈 i 〉 Background/Aims: 〈 /i 〉 〈 /b 〉 Hyperuricemia has been considered a risk factor for renal disease and cardiovascular disease. However, the potential contribution of hyperuricemia to mortality remains uncertain, and the results in the available literature vary according to kidney function. The aim of this study was to determine the association between hyperuricemia and mortality in patients undergoing percutaneous coronary intervention (PCI) across the interaction of kidney function. 〈 b 〉 〈 i 〉 Method: 〈 /i 〉 〈 /b 〉 We retrospectively reviewed patients who underwent PCI from 2003 to 2009. Propensity scores for hyperuricemia ( 〉 7 mg/dl for males and 〉 6 mg/dl for females) were used to assemble a matched cohort of 693 pairs of patients with and without hyperuricemia for analysis from the 3,201 patients who fulfilled the inclusion criteria among the 4,842 patients who underwent PCI. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 Of the 3,201 patients who underwent PCI and for whom data were available regarding their baseline serum uric acid level, 763 (23.8%) had hyperuricemia. The hyperuricemia-associated hazard ratios (HRs) [95% confidence intervals (CIs)] for all-cause mortality were 1.780 (1.270-2.495) in the unmatched cohort and 1.655 (1.109-2.468) in the matched cohort. The HRs (95% CI) for all-cause mortality among those with and without chronic kidney disease (CKD) were 2.080 (1.318-3.283) and 1.592 (0.778-3.256), respectively (p for interaction, 0.001). 〈 b 〉 〈 i 〉 Conclusions: 〈 /i 〉 〈 /b 〉 Hyperuricemia is an independent risk factor for all-cause mortality in those patients with CKD but not in those without CKD.
Materialart:
Online-Ressource
ISSN:
0250-8095
,
1421-9670
Sprache:
Englisch
Verlag:
S. Karger AG
Publikationsdatum:
2013
ZDB Id:
1468523-1
